(1R,2S,4R)-5-((tert-butyldiphenylsilyl)oxy)-2,4-dimethyl-1-(trimethylstannyl)pentyl diisopropylcarbamate

N4,N4'-bis(4-(9H-carbazol-9-yl)phenyl)-N4,N4'-di(naphthalen-1-yl)-[1,1'-biphenyl]-4,4'-diamine

N4,N4-bis(4-(3,3-dimethyl-2-phenyl-3H-pyrrol-4-yl)phenyl)-N4',N4'-diphenyl-[1,1'-biphenyl]-4,4'-diamine

N4,N4'-bis(4'-(2H-benzo[d][1,2,3]triazol-2-yl)-[1,1'-biphenyl]-4-yl)-N4,N4'-diphenyl-[1,1'-biphenyl]-4,4'-diamine

N4,N4'-bis(4-(2,2-diphenylvinyl)phenyl)-N4,N4'-diphenyl-[1,1'-biphenyl]-4,4'-diamine

N4-([1,1':4',1''-terphenyl]-3-yl)-N4',N4'-bis(4-isopropylphenyl)-N4-(9-phenyl-9H-carbazol-3-yl)-[1,1'-biphenyl]-4,4'-diamine

4,4'-bis(8-(tert-butyl)-11-phenylindolo[3,2-b]carbazol-5(1H,5aH,11H)-yl)-1,1'-biphenyl

5-(4'-(9H-carbazol-9-yl)-[1,1'-biphenyl]-4-yl)-7-phenyl-1,5,5a,7-tetrahydroindolo[2,3-b]carbazole

N-([1,1'-biphenyl]-4-yl)-4'-(3-(benzofuran-2-yl)-6-(naphthalen-1-yl)-9H-carbazol-9-yl)-N-(4-(benzofuran-2-yl)phenyl)-[1,1'-biphenyl]-4-amine

(E)-4-(4-((4'-(diphenylamino)-[1,1'-biphenyl]-4-yl)(phenyl)amino)benzylidene)-1,3-dimethyl-1H-pyrazol-5(4H)-one

3-amino-4,5-dihydroxybenzoic acid

Ropivacaine Related Compound-B (USP)

3-nitro-5-sulfamoylbenzoic acid

(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2- methyl-2H-tetrazol-5-yl)pyridin-3- yl)phenyl)oxazolidin-2-one

3-(dibutylamino)-4-phenoxy-5-sulfamoylbenzoic acid

Canagliflozin Alpha Impurity

2-(1-(3-(pentafluoromercapto)phenyl)-1H-1,2,3-triazol-4-yl)ethanol

((2S,3R,4S,5R,6R)-3,4-bis(benzyloxy)-6-((benzyloxy)methyl)-5-(((2R,3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-((benzyloxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)tributylstannane